PRKAA1 and metabolic disease: A large body of evidence supports the concept that activation of AMPK is beneficial for the prevention and treatment of a variety of chronic diseases, particularly metabolic disorders, such as type 2 diabetes mellitus and the metabolic syndrome (57).